Mesenchymal stem cells in maxillary sinus augmentation: A systematic review with meta-analysis

doi:10.4252/wjsc.v7.i6.976

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6500)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

393

WORD

239

HTML

3242

Figures (1-2)

166

Tables (1-2)

155

Sum=4195

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

905

Download

1400

Sum=2305

Jul 26, 2015 (publication date) through May 21, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Stem Cells. Jul 26, 2015; 7(6): 976-991
Published online Jul 26, 2015. doi: 10.4252/wjsc.v7.i6.976

Table 2 Histomorphometric results of the human studies included in the review

Ref.	Patients	Study design	Histomorphometry (% of newly formed bone)
McAllister et al[74]	5	5 MSA: MSCs + AL	33.0 ± NR (16 wk)
Gonshor et al[75]	18	18 MSA: MSCs + AL	32.5 ± 6.8 (12 wk)
		8 MSA: AL	18.3 ± 10.6 (12 wk)
Duttenhoefer et al[77]	11	12 MSA: BMAC + BBM	NR
		6 MSA: Ficoll + BBM
Rickert et al[78]	12	12 MSA: BMSCs + BBM	NR
		12 MSA: AB + BBM
Kühl et al[79]	13	13 MSA: BMA + BBM	NR
		13 MSA: BMAC + BBM
Wildburger et al[80]	7	7 MSA: BMSCs + BBM	7.4 ± 4.1 (12 wk)
			13.5 ± 5.4 (24 wk)
		7 MSA: BBM	11.8 ± 6.2 (12 wk)
			13.9 ± 8.5 (24 wk)
Sauerbier et al[81]	26	34 MSA: BMAC + BBM	12.6 ± 1.7 (12 wk)
		11 MSA: AB + BBM	14.3 ± 1.8 (12 wk)
Rickert et al[82]	12	12 MSA: BMSCs + BBM	17.7 ± 7.3 (14 wk)
		12 MSA: AB + BBM	12.0 ± 6.6 (14 wk)
Schmelzeisen et al[83]	1	2 MSA: BMAC + BBM	26.9 ± NR (12 wk)
Fuerst et al[84]	12	22 MSA: BMSCs + BBM	17.9 ± 4.6 (24 wk)
Beaumont et al[85]	3	6 MSA: PDSCs + BBM	NR
Shayesteh et al[86]	6	6 MSA: BMSCs + HA/β-TCP	41.3 ± NR (24 wk)
Smiler et al[87]	4	2 MSA: BMSCs + β-TCP	40.0 ± NR (16 wk)
		1 MSA: BMSCs + BBM	13.0 ± NR (16 wk)
		1 MSA: BMSCs + HA	31.0 ± NR (16 wk)
Trautvetter et al[88]	10	10 MSA: PDSCs + PLGA	NR
Mangano et al[89]	1	1 MSA: PDSCs + PLGA	28.8 ± NR
Voss et al[91]	35	50 MSA: PDSCs + PLGA	NR
		63 MSA: AB
Mangano et al[90]	5	5 MSA: PDSCs + PLGA	37.3 ± 19.5 (24 wk)
		5 MSA: HA	54.6 ± 21.1 (24 wk)
Zizelmann et al[92]	20	14 MSA: PDSCs + PLGA	NR
		17 MSA: AB
Schimming et al[93]	27	27 MSA: PDSCs + PLGA	NR
Yamada et al[94]	23	23 MSA: BMSCs + PRP	NR
Ueda et al[95]	6	6 MSA: BMSCs + PRP	NR

MSA: Maxillary sinus augmentation; MSCs: Mesenchymal stem cells; AL: Allograft; NR: Not reported; BMAC: Autologous bone marrow aspirate concentrate; BBM: Bovine bone mineral; BMSCs: Bone marrow stem cells; AB: Autogenous bone; BMA: Bone marrow aspirate; PDSCs: Periosteal derived stem cells; HA/β-TCP: Hydroxyapatite/beta-tricalcium phosphate; PLGA: Polylactid-co-glycolic acid; PRP: Platelet rich in plasma.

Citation: Mangano FG, Colombo M, Veronesi G, Caprioglio A, Mangano C. Mesenchymal stem cells in maxillary sinus augmentation: A systematic review with meta-analysis. World J Stem Cells 2015; 7(6): 976-991
URL: https://www.wjgnet.com/1948-0210/full/v7/i6/976.htm
DOI: https://dx.doi.org/10.4252/wjsc.v7.i6.976